Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Clinical trials show variable lipid effects across GLP-1 receptor agonists, with differences generally modest and correlating with weight loss achieved
Im confident this is first of many conversations well be having about GLP-1 medications for type 1 diabetes
These numbers include dosing errors, contamination events, and allergic reactions to inactive ingredients not present in brand-name formulations
60-Day Guarantee: Includes a 60-day money-back guarantee
Key findings from ATTAIN-1: Participants on the highest dose lost an average of 27.3 lbs, or about 12.4% of their starting body weight, over 72 weeks 6% of participants on the highest dose achieved at least 10% weight loss A subset of participants on the highest dose reached around 15% weight loss Improvements were seen in cardiometabolic markers including cholesterol, waist circumference, and blood pressure Two important notes on these numbers
